Free Trial

Janus Henderson Group PLC Cuts Stake in Doximity, Inc. (NASDAQ:DOCS)

Doximity logo with Medical background

Janus Henderson Group PLC lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 13.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,142,478 shares of the company's stock after selling 322,409 shares during the quarter. Janus Henderson Group PLC owned approximately 1.15% of Doximity worth $114,386,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Barclays PLC boosted its holdings in Doximity by 60.5% in the third quarter. Barclays PLC now owns 53,401 shares of the company's stock valued at $2,327,000 after acquiring an additional 20,125 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of Doximity by 564.1% in the 3rd quarter. Franklin Resources Inc. now owns 83,098 shares of the company's stock valued at $3,487,000 after purchasing an additional 70,585 shares during the last quarter. Wedmont Private Capital acquired a new stake in shares of Doximity during the 4th quarter worth approximately $298,000. FNY Investment Advisers LLC acquired a new position in Doximity in the fourth quarter valued at approximately $613,000. Finally, David J Yvars Group acquired a new position in Doximity in the fourth quarter valued at approximately $1,119,000. 87.19% of the stock is owned by institutional investors.

Insider Buying and Selling at Doximity

In other news, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the transaction, the chief financial officer now owns 357,165 shares in the company, valued at $20,440,552.95. This trade represents a 11.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $56.93, for a total value of $113,860.00. Following the sale, the director now directly owns 16,618 shares of the company's stock, valued at $946,062.74. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on DOCS shares. Piper Sandler upgraded Doximity from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $31.00 to $78.00 in a report on Friday, February 7th. William Blair restated an "outperform" rating on shares of Doximity in a research report on Friday. Morgan Stanley cut their target price on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a report on Thursday, April 24th. Wells Fargo & Company reissued an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. Finally, Leerink Partners raised Doximity from a "market perform" rating to an "outperform" rating and raised their price objective for the stock from $60.00 to $90.00 in a research note on Friday, February 7th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Doximity has an average rating of "Moderate Buy" and a consensus price target of $61.78.

Read Our Latest Stock Report on DOCS

Doximity Trading Down 10.0%

Shares of NASDAQ:DOCS traded down $5.85 during trading on Friday, reaching $52.60. 17,787,810 shares of the company traded hands, compared to its average volume of 2,116,934. Doximity, Inc. has a 52-week low of $23.52 and a 52-week high of $85.21. The business's fifty day moving average is $57.58 and its 200-day moving average is $57.65. The firm has a market capitalization of $9.82 billion, a price-to-earnings ratio of 52.60, a P/E/G ratio of 4.10 and a beta of 1.41.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same period last year, the business earned $0.25 earnings per share. Doximity's revenue was up 17.1% on a year-over-year basis. On average, sell-side analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Articles

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines